Brown & Brown二季度业绩显示并购拉动收入但有机增长偏弱

Oil extends slide as U.S.-Iran talks raise hopes of lasting de-escalation
Introduction & Market Context
Brown & Brown (NYSE:BRO) presented its second quarter 2026 results on July 27, 2026, highlighting strong top-line expansion driven by acquisitions while acknowledging pressure in the core business. The insurance broker reported total revenues of $1.68 billion, up 30.4% year-over-year, though organic revenue excluding contingent commissions declined 0.7%.
The presentation revealed a complex quarter where the Accession acquisition significantly boosted reported results, but underlying business momentum remained modest. Despite initially falling 4.84% in premarket trading following the earnings release, shares have since recovered to $72.03, up 3.34% from the previous close of $69.70, suggesting investor focus has shifted to management’s improved second-half outlook.
Quarterly Performance Highlights
The company’s second quarter financial overview demonstrates the dual nature of its performance, with acquisition-driven growth offsetting organic headwinds. As shown in the following summary of key metrics, Brown & Brown delivered mixed results across its primary financial indicators.
Total revenues reached $1.68 billion, representing 30.4% growth from the prior year period, substantially aided by the Accession acquisition which contributed approximately $410 million in quarterly revenue. However, organic revenue declined 0.7% excluding contingent commissions, though it turned positive at 0.7% when including contingents.
Adjusted diluted earnings per share came in at $1.07, up 3.9% year-over-year but narrowly missing analyst expectations of $1.08. The adjusted EBITDAC margin of 35.7% declined 100 basis points from the prior year, partly reflecting lower interest income compared to the second quarter of 2025 when the company held significant cash ahead of closing the Accession deal.
Year-to-date cash flow from operations reached $608 million, up 13% from the prior year, demonstrating continued strong cash generation. The company also increased its quarterly dividend by 10% to $0.165 per share and deployed $250 million toward share repurchases during the quarter.
Market and Business Environment
Management’s assessment of the operating environment revealed a stabilizing but cautious market backdrop. The following overview outlines key market dynamics affecting the business during the quarter.
Economic growth remained consistent with recent quarters, though hiring stayed modest to flat as companies maintained a cautious posture amid inflationary pressures and geopolitical uncertainties. Rate changes in admitted markets showed slight moderation across most lines compared to the first quarter, with casualty and auto rates continuing to increase while property and workers’ compensation rates remained flat to down.
Catastrophe property rates declined, relatively consistent with first quarter trends though with outliers in certain markets. Excess and surplus casualty rates continued increasing at levels similar to the first quarter. The company completed six smaller acquisitions during the period while continuing to build its M&A pipeline, with capital deployment focused on share repurchases totaling $250 million during the quarter.
Segment Performance Analysis
The company’s two primary operating segments showed divergent trends, with Retail significantly outperforming Specialty Distribution on both organic growth and margin expansion. The following comparison illustrates the organic revenue performance across segments.
The Retail segment demonstrated resilience with organic revenue growth of 1.5% excluding contingents and 2.5% including them, while Specialty Distribution faced headwinds with organic revenue declining 3.5% excluding contingents and 1.6% including them.
Retail Segment Deep Dive
The Retail segment delivered strong overall performance, as detailed in the following financial and operational summary.
Retail total revenues reached $947 million, up 35.9% from the prior year, driven primarily by acquisition activity. Organic revenue growth of 1.5% reflected net new business wins and exposure unit expansion, partially offset by declining catastrophe property rates and lower revenues from a specialty pharmacy business.
Employee benefits rates increased 9% to 11%, while rate changes for most commercial lines remained relatively consistent or moderated slightly compared to the first quarter. Property rates ranged from down 5% to flat, while casualty pricing continued increasing 2% to 5%.
Notably, adjusted EBITDAC grew 46.9% to $282 million, outpacing total revenue growth. The adjusted EBITDAC margin expanded 230 basis points to 29.8%, driven by disciplined expense management, higher contingent commissions, synergy realization from acquisitions, and certain one-time items.
Specialty Distribution Challenges
The Specialty Distribution segment faced more significant headwinds during the quarter, as illustrated in the following performance breakdown.
Total revenues for Specialty Distribution increased 28.1% to $721 million, primarily due to acquisition activity and higher contingent commissions. However, organic revenue declined 3.5% excluding contingents, negatively impacted by declining catastrophe property rates and approximately $10 million related to timing of new business that management expects to materialize in the third quarter.
Despite revenue growth, adjusted EBITDAC margin contracted 400 basis points to 42.7%, though still remaining well above the company average. The margin decline reflected the negative organic revenue performance and investments to increase capabilities in Europe, partially offset by higher contingent commissions and contributions from recent acquisitions.
Detailed Financial Analysis
The comprehensive financial results demonstrate how acquisition activity and adjustments affected reported performance. The following consolidated highlights provide year-over-year comparisons across key metrics.
Weighted average diluted shares outstanding increased by 41 million to 334 million, primarily due to shares issued for the Accession acquisition, partially offset by 9 million shares repurchased during the first half of 2026. This share count increase contributed to the modest 3.9% growth in adjusted diluted earnings per share despite stronger growth in adjusted net income.
The reconciliation between GAAP and adjusted figures reveals the impact of various non-recurring items. The following table details these adjustments for the second quarter of 2026.
Key adjustments to arrive at non-GAAP figures included $110 million in amortization expense, $31 million in acquisition and integration costs, and a $40 million change in estimated acquisition earn-out payables. These adjustments increased reported income before income taxes from $383 million to $480 million on an adjusted basis, with the adjusted income before income taxes margin expanding from 22.9% to 28.6%.
For comparative purposes, the following reconciliation shows the prior year adjustments.
The organic revenue reconciliation provides additional insight into the composition of growth. The following breakdown shows how reported commissions and fees translate to organic revenue metrics by segment.
This reconciliation reveals that while total commissions and fees grew 32.4%, organic revenue declined 0.7% after adjusting for acquisitions totaling $478 million, dispositions, foreign currency translation, and litigation-related impacts. The addition of $61 million in organic contingent commissions turned overall organic revenue growth positive at 0.7%.
Strategic Initiatives and Capital Deployment
Management outlined several strategic priorities focused on technology enablement, talent acquisition, and disciplined capital allocation. The company is continuing its technology agenda as an enabler for the business, making progress on initiatives while leveraging external partners including McKinsey, Accenture, and Anthropic to accelerate strategy and implementation.
The company deployed $500 million toward share repurchases over the first half of 2026, demonstrating commitment to returning capital to shareholders while maintaining flexibility for strategic acquisitions. Management indicated that capital will continue to be deployed toward share repurchases, internal investments, and debt paydowns, while M&A focus will primarily target specialty businesses.
The Accession integration is progressing according to plan, with management reaffirming synergy targets of $30 million to $40 million for the full year 2026.
Forward-Looking Statements and Outlook
Management provided an improved outlook for the remainder of 2026, expecting organic growth to accelerate in the second half. The following commentary outlines key expectations and strategic priorities.
For the Retail segment, management projected organic revenue growth excluding contingents of 1.5% to 2.5% for the second half, while Specialty Distribution is forecast to deliver 2% to 4% organic growth. The improved outlook for Specialty Distribution reflects expected timing benefits from new business delayed from the second quarter.
Management expects rate changes for most admitted lines in the second half to remain relatively similar to the second quarter. Excess and surplus casualty rates are expected to continue increasing due to the challenging legal environment, while catastrophe property rates are not expected to change materially in the second half versus the first half.
The company reaffirmed its full-year margin outlook, with adjusted EBITDAC margins expected to be roughly flat for 2026 excluding the effect of lower investment income compared to last year. Management noted it does not expect incremental technology spending to rise at this point, with main benefits from AI initiatives expected to become more visible in years three to five, though some gains may materialize sooner.
The company maintains flexibility around a $400 million debt maturity in December and will decide in the fourth quarter whether to refinance or repay it.
Challenges and Risk Factors
While the presentation emphasized growth opportunities, several challenges emerged from both the company’s disclosures and actual results. The negative organic revenue growth excluding contingents raises questions about core demand momentum, particularly in the Specialty Distribution segment where pricing pressure in catastrophe property lines continues to impact results.
The company expects a $50 million to $60 million full-year revenue impact from litigation-related employee departures to a startup broker, representing a headwind to organic growth. Additionally, margin pressure from lower interest income and mix effects contributed to the 100 basis point decline in adjusted EBITDAC margin.
Competitive market conditions remain challenging, with admitted markets and programs competing more aggressively in excess and surplus lines, potentially limiting pricing power in certain segments. Management noted that catastrophe property rates in Southeast Florida have returned to 2017 levels after a significant rise and subsequent decline.
Despite these near-term challenges, the company’s long-term positioning appears intact, with strong cash generation, disciplined capital allocation, and improving second-half expectations supporting the investment thesis. The stock’s recovery from initial post-earnings weakness to trade up 3.34% suggests investors are focusing on the improved outlook rather than the modest quarterly misses.
Full presentation:
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.